Part 1. Introduction

• 1.1 Market Definition
• 1.2 Key Benefit
• 1.3 Market Segment

Part 2. Methodology

• 2.1 Primary
• 2.2 Secondary

Part 3. Executive Summary

Part 4. Market Overview

• 4.1 Introduction
• 4.2 Market Size and Forecast
• 4.3 Market Dynamics
  • 4.3.1 Drivers
  • 4.3.2 Restraints
• 4.4 Impact of COVID-19 Pandemic on Global Economy
• 4.5 Porter's Five Forces Analysis
  • 4.5.1 Bargaining Power of Suppliers
  • 4.5.2 Bargaining Power of Consumers
  • 4.5.3 Threat of New Entrants
  • 4.5.4 Threat of Substitute Products and Services
  • 4.5.5 Degree of Competition

Part 5. Global Market for Aesthetic Medicine by Product

• 5.1 Market Overview
• 5.2 Invasive Procedures
  • 5.2.1 Market Size and Forecast
• 5.3 Non-invasive Procedures
  • 5.3.1 Market Size and Forecast

Part 6. Global Market for Aesthetic Medicine by Application

• 6.1 Market Overview
• 6.2 Beauty Center
  • 6.2.1 Market Size and Forecast
• 6.3 Clinic
  • 6.3.1 Market Size and Forecast
• 6.4 Hospital
  • 6.4.1 Market Size and Forecast
• 6.5 Medical Spa
  • 6.5.1 Market Size and Forecast

Part 7. Global Market for Aesthetic Medicine by Geography

• 7.1 Overview
  • 7.1.1 Market Size and Forecast
• 7.2 North America
  • 7.2.1 Market Size and Forecast
  • 7.2.2 North America: Aesthetic Medicine Market by Country
    • 7.2.2.1 United States
    • 7.2.2.2 Canada
    • 7.2.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Market Size and Forecast
  • 7.3.2 Europe: Aesthetic Medicine Market by Country
    • 7.3.2.1 Germany
    • 7.3.2.2 France
    • 7.3.2.3 United Kingdom
    • 7.3.2.4 Italy
    • 7.3.2.5 Rest of The Europe
• 7.4 Asia-Pacific
  • 7.4.1 Market Size and Forecast
  • 7.4.2 Asia-Pacific: Aesthetic Medicine Market by Country
    • 7.4.2.1 China
    • 7.4.2.2 India
    • 7.4.2.3 Japan
    • 7.4.2.4 South Korea
    • 7.4.2.5 ASEAN Countries
• 7.5 Middle East and Africa (MEA)
  • 7.5.1 Market Size and Forecast
  • 7.5.2 MEA: Aesthetic Medicine Market by Country
    • 7.5.2.1 Saudi Arabia
    • 7.5.2.2 South Africa
    • 7.5.2.3 Turkey
• 7.6 South America
  • 7.6.1 Market Size and Forecast
  • 7.6.2 South America: Aesthetic Medicine Market by Country
    • 7.6.2.1 Brazil
    • 7.6.2.2 Argentina
    • 7.6.2.3 Rest of South America

  Part 8. Competitive Landscape

  • 8.1 Market Share
  • 8.2 Mergers & Acquisitions, Agreements, Collaborations and Partnerships

  Part 9. Key Competitor Profiles

  • 9.1 AbbVie Inc. (AlLergan Plc)
  • 9.2 Ipsen S.A.
  • 9.3 Johnson & Johnson
  • 9.4 Medy Tox Inc
  • 9.5 Sientra, Inc.

  *LIST IS NOT EXHAUSTIVE

  Part 10. Patent Analysis

  • 10.1 Patent Statistics
  • 10.2 Regional Analysis
  • 10.3 Trends Analysis

  DISCLAIMER

  ABOUT GEN CONSULTING COMPANY

According to Gen Consulting Company, global aesthetic medicine market is projected to grow at a CAGR of 13.3% during the forecast period 2021-2027.

The report offers a breakdown of market shares by product, including Invasive Procedures, Non-invasive Procedures. By application, the aesthetic medicine market is classified into Beauty Center, Clinic, Hospital, Medical Spa. On the basis of region, the aesthetic medicine industry is analyzed across North America, Europe, Asia-Pacific, South America and MEA (the Middle East, and Africa).

By Product:
- Invasive Procedures
- Non-invasive Procedures

By Application:
- Beauty Center
- Clinic
- Hospital
- Medical Spa

By region, the market is analyzed across North America, Asia Pacific, Europe, Middle East & Africa and South America. This report forecasts revenue growth at global, regional & country level from 2021 to 2027.
- North America (U.S., Canada, Mexico, etc.)
- Asia-Pacific (China, Japan, India, Korea, Australia, Indonesia, Taiwan, Thailand, etc.)
- Europe (Germany, UK, France, Italy, Russia, Spain, etc.)
- Middle East & Africa (Turkey, Saudi Arabia, Iran, Egypt, Nigeria, UAE, Israel, South Africa, etc.)
- South America (Brazil, Argentina, Colombia, Chile, Venezuela, Peru, etc.)

The market research report covers the analysis of key stake holders of the aesthetic medicine market. Some of the leading players profiled in the report include:
- AbbVie Inc. (AlLergan Plc)
- Ipsen S.A.
- Johnson & Johnson
- Medy Tox Inc
- Sientra, Inc.
*list is not exhaustive, request free sample to get a complete list of companies

The base year of the study is 2020, and forecasts run up to 2027.

Research Objective
- To analyze and forecast the market size of global aesthetic medicine market.
- To classify and forecast global aesthetic medicine market based on product, application.
- To identify drivers and challenges for global aesthetic medicine market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in global aesthetic medicine market.
- To conduct pricing analysis for global aesthetic medicine market.
- To identify and analyze the profile of leading players operating in global aesthetic medicine market.

The report is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities. Key target audience are:
- Manufacturers of aesthetic medicine
- Raw material suppliers
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to aesthetic medicine